References
- Jemal M , OuyangZ, XiaYQ. Systematic LC–MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24(1), 2–19 (2009).
- Xu RNX , FanLM, RieserMJ, El-ShourbagyTA. Recent advances in high-throughput quantitative bioanalysis by LC–MS/MS. J. Pharmaceut. Biomed. 44(2), 342–355 (2007).
- Hopfgartner G , BourgogneE. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. Mass Spectrom. Rev. 22(3), 195–214 (2003).
- Viswanathan CT , BansalS, BoothBet al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm. Res. 24(10), 1962–1973 (2007).
- Heberger K . Quantitative structure- (chromatographic) retention relationships. J. Chromatogr. A1158(1–2), 273–305 (2007).
- Kaliszan R . QSRR: quantitative structure-(chromatographic) retention relationships. Chem. Rev. 107(7), 3212–3246 (2007).
- Li H . Validation of an LC–MS/MS method for the determination of RAD001 in human whole blood – method description and validation. DMPKR0800442, 72 (2009).
- Torres-Lapasió JR , García-Alvarez-CoqueMC, RosésM, BoschE, ZissimosAM, AbrahamMH. Analysis of a solute polarity parameter in reversed-phase liquid chromatography on a linear solvation relationship basis. Anal. Chim. Acta515(1), 209–227 (2004).
- Torres-Lapasio JR , Ruiz-AngelMJ, Garcia-Alvarez-CoqueMC. Comparative study of solvation parameter models accounting the effects of mobile phase composition in reversed-phase liquid chromatography. J. Chromatogr. A1166(1–2), 85–96 (2007).
- Tellez A , RosesM, BoschE. Modeling the retention of neutral compounds in gradient elution RP-HPLC by means of polarity parameter models. Anal. Chem. 81(21), 9135–9145 (2009).
- Baczek T . Computer-assisted optimization of liquid chromatography separations of drugs and related substances. Curr. Pharm. Anal. 4(3), 151–161 (2008).
- Baczek T , KaliszanR. Predictive approaches to gradient retention based on analyte structural descriptors from calculation chemistry. J. Chromatogr. A987(1–2), 29–37 (2003).
- Wang CL , SkibicMJ, HiggsREet al. Evaluating the performances of quantitative structure–retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions. J. Chromatogr. A1216(25), 5030–5038 (2009).
- Snyder LR , KirklandJJ, DolanJW. Introduction to Modern Liquid Chromatography. John Wiley & Sons, NJ, USA (2010).
Websites
- US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation (2001). www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf
- European Medicine Agency Guideline. Guideline on bioanalytical method validation (2011). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf
- PubChem Compounds Database (2012). www.ncbi.nlm.nih.gov/pccompound/
- Subirats X, Bosch E, Rosés M. Buffer considerations for LC and LC–MS (2009). www.chromatographyonline.com/lcgc/LC%2FHPLC/Buffer-Considerations-for-LC-and-LCndashMS/ArticleStandard/Article/detail/642207